Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Pratice (Netherlands)

NCT01947985 · clinicaltrials.gov ↗

COMPLETED

Status

208958

Enrollment

INDUSTRY

Sponsor class

Conditions

Venous Thrombosis
Pulmonary Embolism
Atrial Fibrillation
Acute Coronary Syndrome

Interventions

DRUG: Rivaroxoban (Xarelto, Bay59-7939)
DRUG: Standard of care

Sponsor

Bayer

Collaborators

[object Object]